Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 1770-1778, November 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wheeler, G. P.
Right arrow Articles by Bowdon, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheeler, G. P.
Right arrow Articles by Bowdon, B. J.

Some Effects of 1, 3-Bis(2-chloroethyl)-1-nitrosourea upon the Synthesis of Protein and Nucleic Acids in Vivo and in Vitro1

Glynn P. Wheeler and Bonnie J. Bowdon

Kettering-Meyer Laboratory, Southern Research Institute,2 Birmingham, Alabama

In a study of the biochemical effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) 3 experimental systems were used: L1210 ascites cells in vitro; L1210 solid tumors and host livers in vivo; and plasmacytoma-1 and plasmacytoma-1/cyclophosphamide in vivo in hamsters. Formate-14C and adenine-8-14C were used as substrates in each of these systems, and DL-leucine-4,5-3H was also used as a substrate for the L1210 ascites cells in vitro and the L1210 solid tumors in vivo. The following effects of BCNU upon the metabolism of these substrates were observed: (a) inhibition of de novo synthesis of purine ribonucleotides by higher doses of the agent, with resulting inhibition of the incorporation of 14C from formate-14C into the purines of both RNA3 and DNA; (b) no inhibition of the conversion of adenine-8-14C into ribonucleotides; (c) greater inhibition of the conversion of ribonucleotides into components of DNA than into components of RNA; (d) greater inhibition of the synthesis of nucleic acids than of proteins; (e) delayed maximum inhibition of the synthesis of nucleic acids in vivo in solid tumors and host livers (maximum inhibition was observed at intervals of 16–48 hr after administration of the agent).

It was concluded that BCNU has a number of biochemical effects similar to those of several alkylating agents that have been studied in some of the same experimental systems but that much remains to be done to define its site and mode of action precisely.

1 This investigation was supported by the Cancer Chemotherapy National Service Center, National Cancer Institute, under USPHS Contract SA-43-ph-2433 and by a grant from The John A. Hartford Foundation, Inc.

2 Affiliated with Sloan-Kettering Institute for Cancer Research, New York, New York.

Received 3/26/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.